Ac-DEVD-CHO,
acetyl-Asp-Glu-Val-Asp-CHO,
acetyl-aspartyl-glutamyl-valyl-aspartal,
Ac-DEVD-CHO,
169332-60-9,
N-acetyl-asp-glu-val-asp-al,
Caspase-3 Inhibitor I,
acetyl-aspartyl-glutamyl-valyl-aspartal,
Ac-Asp-Glu-Val-Asp-Aldehyde,
AC-ASP-GLU-VAL-ASP-H,
CHEMBL417149,
184179-08-6,
CHEBI:59385,
MFCD00671412,
CPP32/Apopain Inhibitor,
acetyl-Asp-Glu-Val-Asp aldehyde,
acetyl-Asp-Glu-Val-Asp-aldehyde,
N-acetyl-Asp-Glu-Val-Asp aldehyde,
N-acetyl-Asp-Glu-Val-Asp-aldehyde,
(4S)-4-[[(2S)-2-acetamido-4-hydroxy-4-oxobutanoyl]amino]-5-[[(2S)-1-[[(2S)-4-hydroxy-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid,
(4S,7S,10S,13S)-7-(2-carboxyethyl)-4-(carboxymethyl)-13-formyl-10-isopropyl-2,5,8,11-tetraoxo-3,6,9,12-tetraazapentadecan-15-oic acid,
MF 191,
2h5i,
AC1LD91U,
Ac-Asp-Glu-Val-Asp aldehyde,
GTPL6527,
SCHEMBL1674857,
BDBM10246,
C20H30N4O11,
HY-P1001,
ZINC3928290,
1594AH,
s7901,
CS-7676,
AC-29039,
Ac-Asp-Glu-Val-Asp-aldehyde (pseudo acid),
L 761191,
L-valinamide, N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-,
L-Valinamide,N-acetyl-L-a-aspartyl-L-a-glutamyl-N-(2-carboxy-1-formylethyl)-,
N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-L-valinamide,
(4S)-4-{[(1S)-1-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(3S)-3-acetamido-3-formamidopropanoic acid]butanoic acid,
L-Valinamide, N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-(2-carboxy-1-formylethyl)-, (S)-,
L-Valinamide, N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]- (9CI),
N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-valinamide,
Ac-Asp-Glu-Val-Asp-CHO,
D0L9AX,
D0P0XF,
acetyl-Asp-Glu-Val-Asp-CHO,
N-Ac-Asp-Glu-Val-Asp-CHO,
CID644345,
C099158,